Evidence map›Paper›PMID 28669125›Full record

ArticleMolecular neurobiology2018

Development of In Vivo Imaging Tools for Investigating Astrocyte Activation in Epileptogenesis.

Chrysavgi Kostoula, Rosaria Pascente, Teresa Ravizza, Thomas McCown, Susanne Schoch, Annamaria Vezzani, Albert J Becker, Karen M J van Loo

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Chrysavgi KostoulaDepartment of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Rosaria PascenteDepartment of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Teresa RavizzaDepartment of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Thomas McCownUNC Gene Therapy Center, Chapel Hill, NC, 27599, USA.
Susanne SchochSection for Translational Epilepsy Research, Department of Neuropathology, University of Bonn Medical Center, 53105, Bonn, Germany.
Annamaria VezzaniDepartment of Neuroscience, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Albert J BeckerSection for Translational Epilepsy Research, Department of Neuropathology, University of Bonn Medical Center, 53105, Bonn, Germany.
Karen M J van LooSection for Translational Epilepsy Research, Department of Neuropathology, University of Bonn Medical Center, 53105, Bonn, Germany. karen.van_Loo@ukb.uni-bonn.de.
Mario Negri Institute for Pharmacological Research · ITUniversity of Bonn · DEUniversity of North Carolina Health Care · US

Funding

European Union's Seventh Framework Programme (FP7/2007-2013) 602102(EPITARGET)
6 · The paper itself

Abstract

Insights into the dynamic changes in molecular processes occurring in the brain during epileptogenesis can substantially improve our understanding of their pathogenetic relevance. In this context, neuroinflammation is a potential mechanism of epileptogenesis which has recently been investigated in animal models by MRI or PET molecular imaging. Here, we developed an alternative and complementary molecular imaging strategy by designing a serotype 8 recombinant adeno-associated virus (AAV8) harboring promoter fragments of the GFAP or IL-1β promoter and a luciferase reporter gene. Mice were injected intrahippocampally with rAAV8 and treated with intracortical kainic acid to induce status epilepticus (SE) and hence epileptogenesis. In vivo bioluminescence imaging combined with immunohistochemistry revealed a significant activation of the GFAP promoter 24 h and 3 days after kainate-induced SE. For IL-1β, we identified the promoter region required for studying cell-specific induction of the promoter in longitudinal studies. We conclude that the GFAP promoter fragment represents a useful tool for monitoring the in vivo activation of astrocytes with an inflammatory phenotype during epileptogenesis, or under other pathophysiological conditions.

Indexed as

Imaging, Three-DimensionalAnimalsAstrocytesGenes, ReporterGlial Fibrillary Acidic ProteinGreen Fluorescent ProteinsHippocampusHumansInterleukin-1betaKainic AcidLuciferasesLuminescent MeasurementsMaleMiceMice, Inbred C57BLPromoter Regions, GeneticGlial Fibrillary Acidic ProteinGreen Fluorescent ProteinsInterleukin-1betaKainic AcidLuciferasesAdeno-associated viral vectorsEpilepsyGFAPIL-1βIn vivo imaging

Identifiers

PMID28669125
OpenAlexW2727462078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.